Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Adenoid Cystic Carcinoma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Adenoid Cystic Carcinoma

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 2 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      9 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00095563 · Registry condition search · Scope: narrower

      Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00492089 · Registry condition search · Scope: narrower

      Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

      1 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT00859937 · Registry condition search · Scope: narrower

      Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01175980 · Registry condition search · Scope: narrower

      Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01604772 · Registry condition search · Scope: narrower

      Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01806675 · Registry condition search · Scope: narrower

      18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

      5 outcome links · 3 safety-group records · 1 quality-of-life measures

      →

      NCT02123511 · Registry condition search · Scope: narrower

      Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

      6 outcome links · 2 safety-group records · 3 quality-of-life measures

      →

      NCT04895735 · Registry condition search · Scope: narrower

      MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

      6 outcome links · 3 safety-group records · 0 quality-of-life measures

      →

      NCT05010629 · Registry condition search · Scope: narrower

      9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

      6 outcome links · 2 safety-group records · 1 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-adenoid-cystic-carcinoma
        binding id
        ncit-C2970
        source collection
        ncit-concept
        source key
        C2970
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice